| 前收市價 | 17.16 |
| 開市 | 16.98 |
| 買盤 | 17.34 x 1200 |
| 賣出價 | 17.41 x 400 |
| 今日波幅 | 16.77 - 17.52 |
| 52 週波幅 | 15.81 - 41.06 |
| 成交量 | |
| 平均成交量 | 1,973,941 |
| 市值 | 2.112B |
| Beta 值 (5 年，每月) | 0.90 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -4.28 |
| 業績公佈日 | 2024年5月09日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 37.53 |
ZacksWant Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Investor's Business DailyExact Sciences, A Cathie Wood Stock, Surges As Rival Colon Cancer Test Pales
Exact Sciences stock surged Tuesday after the company's colon cancer-screening rival, Freenome, unveiled the results of a pivotal study.
InvestorPlaceBetter Than ChatGPT? New Super AI Bot Says Buy These 3 Stocks.
It’s been nearly one and a half years since ChatGPT went live, but it sure doesn’t feel like it. ChatGPT has shaken up many sectors, and triggered an AI revolution. I would argue that ChatGPT is the biggest reason why the ‘Magnificent 7’ stocks have done so well. This rally, in turn, has driven the broader market higher alongside these stocks. However, this does not mean that ChatGPT is the only AI model in town. Other companies have been racing to make their own AI models. Indeed, many AI model
